The potential impact of pharmacogenetic testing on medication adherence
- PMID: 23999596
- PMCID: PMC3969027
- DOI: 10.1038/tpj.2013.33
The potential impact of pharmacogenetic testing on medication adherence
Abstract
Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.
Figures
References
-
- NEHI. Thinking Outside the Pillbox: A System-wide Approach to Improving Patient Medciation Adherence for Chronic Disease. 2011 http://www.nehi.net/uploads/full_report/pa_issue_brief__final.pdf.
-
- Osterberg L, Blaschke T. Adherence to medication. The New England journal of medicine. 2005;353(5):487–497. - PubMed
-
- Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
